Samsara BioCapital, L.P. - 29 Jun 2021 Form 4 Insider Report for Graphite Bio, Inc. (LENZ)

Role: 10%+ Owner
Signature: Samsara BioCapital, L.P., By: Samsara BioCapital GP, LLC, its General Partner, By /s/ Srinivas Akkaraju, Managing Member
Issuer symbol: LENZ
Transactions as of: 29 Jun 2021
Net transactions value: +$8,500,000
Form type: 4
Filing time: 01 Jul 2021, 17:39:35 UTC
Previous filing: 24 Jun 2021
Next filing: 08 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRPH	Common Stock	Conversion of derivative security		+6,167,763			6,167,763	29 Jun 2021	By Fund	F1, F2
transaction	GRPH	Common Stock	Conversion of derivative security		+741,107	+12%		6,908,870	29 Jun 2021	By Fund	F1, F2
transaction	GRPH	Common Stock	Conversion of derivative security		+22,753			22,753	29 Jun 2021	By Fund	F1, F3
transaction	GRPH	Common Stock	Purchase	$8,245,000	+485,000	+7%	$17.00	7,393,870	29 Jun 2021	By Fund	F2
transaction	GRPH	Common Stock	Purchase	$255,000	+15,000	+66%	$17.00	37,753	29 Jun 2021	By Fund	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GRPH	Series A Redeemable Convertible Preferred Stock	Conversion of derivative security	$0	-15,000,000	-100%	$0.000000^*	0	29 Jun 2021	Common Stock	6,167,763		By Fund	F1, F2
transaction	GRPH	Series B Redeemable Convertible Preferred Stock	Conversion of derivative security	$0	-1,802,372	-100%	$0.000000^*	0	29 Jun 2021	Common Stock	741,107		By Fund	F1, F2
transaction	GRPH	Series B Redeemable Convertible Preferred Stock	Conversion of derivative security	$0	-55,336	-100%	$0.000000^*	0	29 Jun 2021	Common Stock	22,753		By Fund	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a one-for-2.432 basis, and had no expiration date.
F2	Shares held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein.
F3	Shares held by 436, L.P. ("436 LP"). 436, LLC ("436 LLC") is the general partner of 436 LP and may be deemed to beneficially own the shares held by 436 LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by 436 LP and, accordingly, may be deemed to beneficially own the shares held by 436 LP. Each of 436 LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein.